Aspira Pathlab & Diagnostics (BOM:540788) ROCE % : -13.26% (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Aspira Pathlab & Diagnostics ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Aspira Pathlab & Diagnostics's annualized ROCE % for the quarter that ended in Mar. 2024 was -13.26%.

Aspira Pathlab & Diagnostics ROCE % Historical Data

The historical data trend for Aspira Pathlab & Diagnostics's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aspira Pathlab & Diagnostics ROCE % Chart

Aspira Pathlab & Diagnostics Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

ROCE %

Get a 7-Day Free Trial

-32.59

22.86

36.52

2.05

-16.23

Aspira Pathlab & Diagnostics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															-4.15	-15.69	-17.45	-18.56	-13.26

Aspira Pathlab & Diagnostics ROCE % Calculation

Aspira Pathlab & Diagnostics's annualized ROCE % for the fiscal year that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2024 )		(A: Mar. 2023 )		(A: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2024 )		(A: Mar. 2023 )		(A: Mar. 2024 )
	=	-23.045	/	( ( (173.417 - 15.848)	+	(147.096 - 20.71) )	/ 2 )
	=	-23.045	/	( (157.569	+	126.386)	/ 2 )
	=	-23.045	/	141.9775
	=	-16.23 %

Aspira Pathlab & Diagnostics's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	-16.756	/	( ( (0 - 0)	+	(147.096 - 20.71) )	/ 1 )
	=	-16.756	/	( ( 0	+	126.386 )	/ 1 )
	=	-16.756	/	126.386
	=	-13.26 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Aspira Pathlab & Diagnostics (BOM:540788) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Aspira Pathlab & Diagnostics ROCE % Related Terms

Thank you for viewing the detailed overview of Aspira Pathlab & Diagnostics's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Aspira Pathlab & Diagnostics (BOM:540788) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Aspira Pathlab & Diagnostics Ltd (BOM:540788) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

6 & 7, Bhaveshwar Arcade, Near Shreyas Junction LBS Marg, Behind Saraswat Bank, Ghatkopar (west), Mumbai, MH, IND, 400086

Website

https://www.aspiradiagnostics.com

Aspira Pathlab & Diagnostics Ltd is an India based company, engages in the provision of healthcare facilities. It offers a wide range of diagnostic services for various types of diseases. Its activities consist of pathology investigation services, radiology investigation services, and other related healthcare services. Geographically, it operates only in India.

Aspira Pathlab & Diagnostics (BOM:540788) Headlines

No Headlines